Chromium Supplementation Does Not Improve Glucose Tolerance, Insulin Sensitivity, or Lipid Profile
The DOI matches its Crossref record.
Abstract
Chromium supplements are thought to be the second most commonly taken nutritional supplement, used by an estimated 10 million Americans (1). Chromium is an essential element in humans, and deficiency is associated with the development of diabetes, which was first noted in patients receiving long-term parenteral nutrition before the advent of routine chromium supplementation (2,3). In these patients, diabetes resolved following chromium replacement (2–4). The dietary requirement for chromium is controversial, with the recommended daily intake in the U.S. being 0.05–0.20 μg (5). Chromium is abundant in the environment; however, aside from the extreme situation of unsupplemented parenteral nutrition, it has proven difficult to ascertain any clinical effects, due solely to chromium deficiency. Despite these difficulties, chromium supplements are widely promoted in the complementary health industries. There are many studies examining the effects of various forms of chromium supplementation (rev. in 6,7). These studies utilized a variety of chromium formulations, varying doses, and patients with normal glucose tolerance, diabetes, or gestational diabetes. The outcomes have been inconsistent. Some studies showed no benefit, and other studies have shown inconsistent improvements in glucose, insulin resistance, and/or lipids. The paucity of data has prompted the National Institutes of Health to release a program announcement to address the issue: “Chromium as an adjuvant therapy …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Bantle (2008) · doi:10.2337/dc08-s061 · Cited by 1,795
Effect of Chromium Supplementation on Glucose Metabolism and Lipids
Balk, E. M., Tatsioni, A., Lichtenstein, A. H., Lau, J., & Pittas, A. G. (2007) · Diabetes Care · doi:10.2337/dc06-0996 · Cited by 294
Scientific Opinion on Dietary Reference Values for chromium
EFSA Panel on Dietetic Products, N. A. A. (. (2014) · EFSA Journal · doi:10.2903/j.efsa.2014.3845 · Cited by 266
“In most studies, chromium intake from the diet was not assessed and information on total chromium intake is therefore not available (Riales and Albrink, 1981; Anderson et al., 1983b; Offenbacher et al., 1985; Anderson et al., 1987; Press et al., 1990; Hermann et al., 1994; Boyd et al., 1998; Hermann et al., 1998; Cefa…”
Nutrition Recommendations and Interventions for Diabetes–2006
American Diabetes Association (2006) · Diabetes Care · doi:10.2337/dc06-9914 · Cited by 205
Hypoxia-inducible factors and diabetes
Gunton, J. E. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137556 · Cited by 159
“However, serum chromium levels do not correlate with metabolic features in women with gestational diabetes (78), and randomized controlled trials of chromium supplementation in people with abnormal glucose tolerance show no beneficial effects on glucose homeostasis (79, 80), even with a documented rise in serum chromi…”
BackgroundSelf-citation
Metadata
- Authors
- Gunton, J. E., Cheung, N. W., Hitchman, R., Hams, G., O’Sullivan, C., Foster-Powell, K., & McElduff, A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2005-03-01
- Volume
- 28
- Issue
- 3
- Pages
- 712-713
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W1992852598
- Cited by
- 73
- References
- 0
- FWCI
- 6.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chromium Supplementation Does Not Improve Glucose Tolerance, Insulin Sensitivity, or Lipid Profile. https://app.cochat.ai/papers/10.2337/diacare.28.3.712
- The paper
- Gunton, J. E., Cheung, N. W., Hitchman, R., Hams, G., O’Sullivan, C., Foster-Powell, K., & McElduff, A. (2005). Chromium Supplementation Does Not Improve Glucose Tolerance, Insulin Sensitivity, or Lipid Profile. Diabetes Care. https://doi.org/10.2337/diacare.28.3.712
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.